Abstract
Importance Anterior chamber paracentesis (ACP) is a known method of rapid reduction of IOP. The mechanism of how corneal fluid clears after ACP is not well described.
Objective To determine the mechanism of instantaneous corneal clearing of edema after ACP.
Design, setting, and participants This case series includes consecutive patients with high IOP and associated corneal edema, who presented to the Glaucoma Services of our tertiary care center. Pre- and post-intervention (ACP) ASOCTs were analyzed.
Main outcome measures Resolution of corneal edema (clinical picture) and imaging of peripheral cornea and iridocorneal angle area.
Results Ten consecutive patients who underwent an ACP were included in this study. The mean IOP pre-intervention was 48.4 ± 8.2 mmHg. ASOCT showed ill-defined conventional pathways of aqueous outflow, which were blocked by peripheral anterior synechiae in 4 eyes. Immediately post ACP, the IOP was 16.3 ± 5.6 mmHg (p < 0.001) and corneal edema resolved immediately. We found on ASOCT, that the intrastromal hypolucency of the peripheral cornea, (corneal cistern) which was limited in extent and U shaped, showed a posterior extension into the corneo-limbal junction to form well-defined anastomoses with the conventional aqueous drainage channels demonstrating a direct conduit for intracorneal fluid to egress. In 2/10 eyes, Schlemm’s canal opened intracamerally as well, suggesting direct reflux of intra-corneal fluid into the anterior chamber.
Conclusion and Relevance After an ACP, in eyes with corneal edema to relieve IOP, we observed that the intracorneal cisterns undergo peripheral extension to drain corneal fluid through the conventional distal outflow channels.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was given by the Ethics Committee of All India Institute of Medical Sciences, New Delhi.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration: None of the authors have any conflicts of interest related to this submission
Data Availability
All data produced in the present study are available upon reasonable request to the authors
